Skip to main content
OpenTrials
Completed

NCT Number: NCT02535741

Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee

An open label, post-market, non-randomised, historical controlled, multi-centre study of the outcomes of the Triathlon Cruciate Retaining (CR) Total Knee System.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Total Knee Arthroplasty

Age range

21 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Koge Sygehus, Køge, Roskilde, Denmark

Loading trial locations.

About this study

An open label, post-market, non-randomised, historical controlled, multi-centre study of the outcomes of the Triathlon Cruciate Retaining (CR) Total Knee System. The primary objective of this study will be to compare the active range of motion values for the Triathlon CR Total Knee System with those of the Scorpio CR Total Knee System, a historical control group. ROM values will be measured by use of a Goniometer according to the protocol. It is expected that the Triathlon CR Total Knee System group's range of motion is not 5 degrees worse or superior to the control group's range of motion at two-years.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients willing to sign the Ethic Commission approved, study specific Informed Patient Consent Form.
  • Patients willing and able to comply with scheduled postoperative clinical and radiographic evaluations and rehabilitation.
  • Male or non-pregnant female between the ages of 21-80 years of age at the time of surgery.
  • Patients requiring a primary total knee replacement.
  • Patients with a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN).
  • Patients with intact collateral ligaments.

Exclusion criteria

  • Patients with inflammatory arthritis.
  • Patients that are morbidly obese, body mass index (BMI) > 40.
  • Patients with a history of total / unicompartmental reconstruction of the affected joint.
  • Patients that have had a high tibial osteotomy or femoral osteotomy.
  • Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • Patients with a systemic or metabolic disorder leading to progressive bone deterioration.
  • Patients that are immunologically compromised, or receiving chronic steroids (>30 days duration).
  • Patients bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis.
  • Patients with a knee fusion to the affected joint.
  • Patients with an active or suspected latent infection in or about the knee joint.
  • Patients with a history of total joint replacement on the opposite knee within less than 1 year.
  • Patients requiring bilateral total knee replacement.

Treatment and study plan

Triathlon CR Total Knee System

Device

Primary total knee replacement

Primary outcomes

  1. Mean Triathlon CR Active Range of Motion (ROM)

    Time frame: 2 years follow-up

    Comparison of the active ROM values for patients receiving the Triathlon CR Total Knee System with historical active ROM values of the Scorpio CR Total Knee System, a control group by literature review at 2 years post Total Knee Arthroplasty. See Chaudhary R, et al 2008 JBJS included for historical control data.

Secondary outcomes

  1. Investigation of Patient Outcome With Radiographic Analysis

    Time frame: Pre-operative, 3 months, 1, 2 and 5 years follow-up

    Plain radiographs will be obtained for assessment of fixation of the device.

  2. Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)

    Time frame: Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up

    The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, Range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.

  3. Investigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire

    Time frame: Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up

    The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical (PSC) and mental status component (MCS) score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

  4. Investigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire

    Time frame: Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up

    The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes.

Sponsors and collaborators

Lead sponsor

Stryker Orthopaedics

Industry

Registry information

Official study title

Clinical Outcome Study for the Triathlon CR Total Knee

Acronym: TriathlonCR

Important dates

Study start
2006
Primary completion
2013
Study completion
2016
First posted
Aug 31, 2015
Registry last updated
Feb 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.